Document is current
Any future updates will be listed below
-
Authors
Tiainen, Satu http://orcid.org/0000-0002-5673-8851
Rilla, Kirsi
Hämäläinen, Kirsi
Oikari, Sanna
Auvinen, Päivi
-
Funding
Funding for this research was provided by:
Finnish Society for Oncology
Ida Montinin Säätiö
Special Government Funding of Kuopio University Hospital (1V315, 5654132)
University of Eastern Finland (UEF) including Kuopio University Hospital
- License Information
-
More Information
Article History
Received: 23 May 2020
Accepted: 2 September 2020
First Online: 18 September 2020
Compliance with ethical standards
:
: Satu Tiainen has received financial support for attending conferences and honoraria for speaking at symposia and participating in advisory boards from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, MSD, Novartis, Pfizer, Roche and Takeda. None of the financial support regarded this study. Päivi Auvinen reports funding from Roche for attending ESMO Breast Cancer Congress 2019. All other authors declare that they have no conflict of interest.
: All procedures performed in this study were in accordance with the ethical standards of The Ethics Committee of the University of Eastern Finland (February 24, 2009, 19//2009), and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Informed consent was not required since this retrospective study was conducted on already existing material, and acquiring informed consent from all the patients would not have been possible.
